Responder versus nonresponder comparisons: daunorubicin plus prednisone in treatment of acute nonlymphocytic leukemia.
D000208:Acute Disease; D003630:Daunorubicin / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use*
D011241:Prednisone; D003630:Daunorubicin